Skip to content

Released Aug 12, 2011

10-Q filed Aug 12, 2011, 43 days after period end · 0001104659-11-046310

Q2 2011 · 10-Q
Revenue$11.26M+22.6% vs Q2 2010+10.0% vs Q1 2011
Net Income-$18.84MN/M vs Q2 2010N/M vs Q1 2011
EPS Diluted-$0.19N/M vs Q2 2010N/M vs Q1 2011
Operating Income-$18,952,000N/M
Operating Cash Flowderived-$18,208,000—
Free Cash Flowderived-$20,207,000—
Margins · derived
Operating margin-168.3%+20.1 pt vs Q2 2010
Net margin-167.3%+19.2 pt vs Q2 2010

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2011Q2 2010
Revenue$11.26M$9.19M
Net Income-$18.84M-$17.14M
EPS Diluted-$0.19-$0.18

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR